Work

Clinical applicability of renin-angiotensin system inhibitors in cancer treatment.

Year: 2021

Type: review

Abstract: , an essential component of RAS, on tumors, and we discuss the underlying biological mechanism of RASi. Furthermore, we outline the research progress and potential use of RASi in tumor treatment. Overall, RASi may be a promising adjunct in cancer therapy.

Source: PubMed

Authors: Huirong Jiang, Zongguang Tai, Zhongjian Chen, Quangang Zhu, Leilei Bao

Institutions: Tongji University, Bengbu Medical College, Second Military Medical University, Changhai Hospital, Eastern Hepatobiliary Surgery Hospital, Shanghai Skin Disease Hospital

Language: English

Topic: Renin-Angiotensin System Studies

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3128048583

FWCI: 0.676

Cites: 70

Cited by: 18

Related to: 10